Fig. 2From: Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)Volume of interest (VOIs) of the kidneys, liver, spleen, and tumors drawn using the General Electric Dosimetry toolkit softwareBack to article page